Yeshwant Krishna

Yeshwant Krishna is listed in filings as Director, 10% Owner at Verve Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 28, 2025, including 5 public disclosures. Recent filings connect the profile to Verve Therapeutics, Inc. (VERV). The current snapshot covers public activity from Jun 28, 2024 to Jul 28, 2025. Reported amounts are shown as $683.4K to $18.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.